{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:24:41Z","timestamp":1794374681745,"version":"4.9.0"},"reference-count":184,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013030","name":"William and Ella Owens Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA203108"],"award-info":[{"award-number":["R01 CA203108"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA247234"],"award-info":[{"award-number":["R01 CA247234"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ccell.2026.03.012","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:11:42Z","timestamp":1776352302000},"page":"913-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cancer cachexia: A tumor-driven disorder of whole-body homeostasis"],"prefix":"10.1016","volume":"44","author":[{"given":"Yuqing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Nipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Janowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis C.","family":"Guttridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-9130","authenticated-orcid":false,"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2026.03.012_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ccell.2026.03.012_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMcibr1106880","article-title":"Cancer cachexia and fat-muscle physiology","volume":"365","author":"Fearon","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib3","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: A systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib4","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1002\/onco.13774","article-title":"Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss","volume":"26","author":"Best","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.ccell.2026.03.012_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.6004\/jnccn.2020.7618","article-title":"Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer","volume":"19","author":"van Seventer","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ccell.2026.03.012_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2026.03.012_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.trecan.2022.01.004","article-title":"Emerging signaling mediators in the anorexia-cachexia syndrome of cancer","volume":"8","author":"Talbert","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib8","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/s42255-024-01167-9","article-title":"Cancer cachexia: multilevel metabolic dysfunction","volume":"6","author":"Berriel Diaz","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib9","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/annonc\/mdw420","article-title":"Perspectives of health care professionals on cancer cachexia: results from three global surveys","volume":"27","author":"Muscaritoli","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188359","article-title":"Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions","volume":"1873","author":"Siddiqui","year":"2020","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib13","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1158\/1078-0432.CCR-16-0495","article-title":"Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment","volume":"22","author":"Miyamoto","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200420174","article-title":"Cancer cachexia is regulated by selective targeting of skeletal muscle gene products","volume":"114","author":"Acharyya","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2026.03.012_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bjc.6601712","article-title":"The response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing patients with pancreatic cancer","volume":"90","author":"Barber","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib16","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1158\/0008-5472.CAN-15-3152","article-title":"Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia","volume":"76","author":"Chen","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/sj.bjc.6603446","article-title":"Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer","volume":"95","author":"Deans","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000658-199101000-00005","article-title":"Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer","volume":"213","author":"Fearon","year":"1991","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ccell.2026.03.012_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Scheede-Bergdahl","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ccell.2026.03.012_bib20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2026.03.012_bib21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1053\/j.gastro.2018.10.026","article-title":"ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells","volume":"156","author":"Yang","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2026.03.012_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.740548","article-title":"Extracellular Vesicles and DAMPs in Cancer: A Mini-Review","volume":"12","author":"Abu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2026.03.012_bib23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jcsm.12851","article-title":"Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole","volume":"13","author":"Liu","year":"2022","journal-title":"J. cachexia sarcopenia muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ccell.2026.03.012_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41467-017-00726-x","article-title":"Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.012_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib27","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jcsm.12145","article-title":"Activin A induces skeletal muscle catabolism via p38beta mitogen-activated protein kinase","volume":"8","author":"Ding","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131870","article-title":"Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans","volume":"5","author":"Laurens","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ccell.2026.03.012_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","article-title":"GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans","volume":"29","author":"Patel","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s42255-025-01264-3","article-title":"GDF15 links adipose tissue lipolysis with anxiety","volume":"7","author":"Townsend","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib32","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","article-title":"GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance","volume":"178","author":"Luan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948804","article-title":"Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress","volume":"21","author":"Ost","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ccell.2026.03.012_bib34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cmet.2023.06.016","article-title":"GDF15 increases insulin action in the liver and adipose tissue via a beta-adrenergic receptor-mediated mechanism","volume":"35","author":"Sj\u00f8berg","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106868118","article-title":"Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15","volume":"118","author":"Cimino","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2026.03.012_bib36","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jcsm.12346","article-title":"Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice","volume":"9","author":"Kandarian","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.03.012_bib38","doi-asserted-by":"crossref","first-page":"E144","DOI":"10.1152\/ajpendo.00187.2022","article-title":"Brown adipose tissue is not associated with cachexia or increased mortality in a retrospective study of patients with cancer","volume":"324","author":"Eljalby","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib39","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jcsm.12565","article-title":"The expression landscape of cachexia-inducing factors in human cancers","volume":"11","author":"Freire","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/jcsm.12756","article-title":"Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis","volume":"12","author":"Martin","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.012_bib44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","article-title":"The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ccell.2023.02.007","article-title":"Cancer cachexia: involvement of an expanding macroenvironment","volume":"41","author":"Pryce","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ccell.2026.03.012_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12976-015-0015-0","article-title":"Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia","volume":"12","author":"Friesen","year":"2015","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.ccell.2026.03.012_bib48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.aaf5171","article-title":"Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers","volume":"353","author":"Mayers","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ccell.2026.03.012_bib49","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2022.06.058","article-title":"Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer","volume":"163","author":"Zhou","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2026.03.012_bib50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib51","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847258","article-title":"Energy metabolism in cachexia","volume":"20","author":"Rohm","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ccell.2026.03.012_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13550-021-00834-2","article-title":"Imaging modalities for diagnosis and monitoring of cancer cachexia","volume":"11","author":"Han","year":"2021","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/PPO.0000000000000716","article-title":"PET Imaging of Metabolism, Perfusion, and Hypoxia: FDG and Beyond","volume":"30","author":"Pantel","year":"2024","journal-title":"Cancer J."},{"key":"10.1016\/j.ccell.2026.03.012_bib54","first-page":"983","article-title":"Use of PET for monitoring cancer therapy and for predicting outcome","volume":"46","author":"Weber","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib55","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ccell.2026.03.012_bib56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcsm.12029","article-title":"Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients","volume":"6","author":"van Dijk","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib57","first-page":"219","article-title":"Symptoms in advanced pancreatic cancer are of importance for energy intake","volume":"21","author":"Bye","year":"2013","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","article-title":"The interplay of immunology and cachexia in infection and cancer","volume":"22","author":"Baazim","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2026.03.012_bib59","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib60","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/jcsm.13236","article-title":"Cachexia causes time-dependent activation of the inflammasome in the liver","volume":"14","author":"das Neves","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib61","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2026.03.012_bib62","doi-asserted-by":"crossref","first-page":"C310","DOI":"10.1152\/ajpcell.00317.2024","article-title":"Exploring heterogeneity: a dive into preclinical models of cancer cachexia","volume":"327","author":"Morena","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ccell.2026.03.012_bib63","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1038\/s41467-023-40024-3","article-title":"Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer","volume":"14","author":"Babic","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.012_bib64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib65","doi-asserted-by":"crossref","first-page":"168","DOI":"10.21037\/tlcr-22-561","article-title":"The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative review","volume":"12","author":"Morita-Tanaka","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib66","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Chen","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.ccell.2026.03.012_bib67","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/onc.2016.437","article-title":"Blockade of the IL-6 trans-signalling\/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma","volume":"36","author":"Miller","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2026.03.012_bib68","first-page":"396","article-title":"The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome","volume":"20","author":"van Norren","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ccell.2026.03.012_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrclinonc.2015.200","article-title":"Cachexia in patients with oesophageal cancer","volume":"13","author":"Anandavadivelan","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines(\u2606)","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.ccell.2026.03.012_bib71","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3748\/wjg.v25.i31.4383","article-title":"Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance","volume":"25","author":"Tuomisto","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ccell.2026.03.012_bib72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/bjs.4038","article-title":"Systemic inflammatory response predicts survival following curative resection of colorectal cancer","volume":"90","author":"McMillan","year":"2003","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ccell.2026.03.012_bib73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib74","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajpath.2012.12.023","article-title":"Autophagic degradation contributes to muscle wasting in cancer cachexia","volume":"182","author":"Penna","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2026.03.012_bib75","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ccell.2026.03.012_bib76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13539-012-0071-9","article-title":"Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency","volume":"3","author":"Julienne","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib78","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jcsm.12232","article-title":"Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice","volume":"8","author":"Brown","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2044-5040-2-14","article-title":"IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin\/+ mouse","volume":"2","author":"White","year":"2012","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib80","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1152\/japplphysiol.00746.2021","article-title":"Skeletal muscle mitochondrial dysfunction and muscle and whole body functional deficits in cancer patients with weight loss","volume":"132","author":"Kunz","year":"2022","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ccell.2026.03.012_bib81","article-title":"Complement pathway activation mediates pancreatic cancer-induced muscle wasting and pathological remodeling","volume":"135","author":"D'Lugos","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2026.03.012_bib82","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2010.01.002","article-title":"Crosstalk pathways between Toll-like receptors and the complement system","volume":"31","author":"Hajishengallis","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ccell.2026.03.012_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9592","article-title":"Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia","volume":"13","author":"Sartori","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib84","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2026.03.012_bib85","doi-asserted-by":"crossref","first-page":"311","DOI":"10.15698\/cst2018.11.163","article-title":"p38beta MAPK mediates ULK1-dependent induction of autophagy in skeletal muscle of tumor-bearing mice","volume":"2","author":"Liu","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.ccell.2026.03.012_bib86","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/emboj.2011.292","article-title":"C\/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1\/MAFbx upregulation and muscle wasting","volume":"30","author":"Zhang","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2026.03.012_bib87","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1096\/fj.12-222711","article-title":"Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2","volume":"27","author":"Zhang","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ccell.2026.03.012_bib88","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200215119","article-title":"UBR2 targets myosin heavy chain IIb and IIx for degradation: Molecular mechanism essential for cancer-induced muscle wasting","volume":"119","author":"Gao","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2026.03.012_bib89","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1158\/0008-5472.CAN-18-1653","article-title":"p300 Mediates Muscle Wasting in Lewis Lung Carcinoma","volume":"79","author":"Sin","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib90","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2044-5040-2-20","article-title":"p38beta MAPK upregulates atrogin1\/MAFbx by specific phosphorylation of C\/EBPbeta","volume":"2","author":"Zhang","year":"2012","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib91","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1158\/0008-5472.CAN-19-3219","article-title":"Cancer-Induced Muscle Wasting Requires p38beta MAPK Activation of p300","volume":"81","author":"Sin","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.784424","article-title":"Weight Loss in Cancer Patients Correlates With p38beta MAPK Activation in Skeletal Muscle","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ccell.2026.03.012_bib93","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/jcsm.12461","article-title":"The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy","volume":"10","author":"Zhong","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib94","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ccell.2026.03.012_bib95","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib96","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/nm.4171","article-title":"An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice","volume":"22","author":"Rohm","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239990","article-title":"Brown fat does not cause cachexia in cancer patients: A large retrospective longitudinal FDG-PET\/CT cohort study","volume":"15","author":"Becker","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2026.03.012_bib98","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.3748\/wjg.14.3672","article-title":"Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells","volume":"14","author":"Edderkaoui","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ccell.2026.03.012_bib99","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2310\/JIM.0b013e3181cf91ca","article-title":"Adipokines in patients with cancer anorexia and cachexia","volume":"58","author":"Smiechowska","year":"2010","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib100","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cncr.21690","article-title":"Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients","volume":"106","author":"Wolf","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib101","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","article-title":"Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management","volume":"20","author":"Argil\u00e9s","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib102","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.cell.2025.06.010","article-title":"Brain control of energy homeostasis: Implications for anti-obesity pharmacotherapy","volume":"188","author":"Johansen","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib103","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1002\/jcsm.13093","article-title":"Lipopolysaccharide-induced hypothalamic inflammation in cancer cachexia-anorexia is amplified by tumour-derived prostaglandin E2","volume":"13","author":"Li","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib104","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/jcsm.12939","article-title":"Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice","volume":"13","author":"Martin","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1210\/en.2009-0865","article-title":"Hypothalamic actions of tumor necrosis factor alpha provide the thermogenic core for the wastage syndrome in cachexia","volume":"151","author":"Arruda","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ccell.2026.03.012_bib106","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib107","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101441","article-title":"Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing","volume":"58","author":"Huisman","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/science.adm8857","article-title":"A neuroimmune circuit mediates cancer cachexia-associated apathy","volume":"388","author":"Zhu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.ccell.2026.03.012_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121931","article-title":"Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors","volume":"11","author":"Wiggs","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ccell.2026.03.012_bib111","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1038\/s44318-025-00458-5","article-title":"Translocation of gut bacteria promotes tumor-associated mortality by inducing immune-activated renal damage","volume":"44","author":"Cong","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2026.03.012_bib112","first-page":"482","article-title":"Understanding the gut microbiota in cancer cachexia","volume":"26","author":"Rocha","year":"2023","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ccell.2026.03.012_bib113","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/annonc\/mdu086","article-title":"Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA)","volume":"25","author":"Blum","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2026.03.012_bib115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1634\/theoncologist.2019-0813","article-title":"Leveraging the Potential Synergy Between Patient-Reported Outcomes and Body Composition Analysis in Patients with Cancer","volume":"25","author":"van Seventer","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.ccell.2026.03.012_bib116","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1210\/me.2013-1194","article-title":"Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo","volume":"27","author":"Goodman","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ccell.2026.03.012_bib117","first-page":"823","article-title":"Peripheral blood cells from weight-losing cancer patients control the hepatic acute phase response by a primarily interleukin-6 dependent mechanism","volume":"15","author":"O'Riordain","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib118","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/cs0920215","article-title":"Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6","volume":"92","author":"Wigmore","year":"1997","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ccell.2026.03.012_bib119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00000658-199404000-00001","article-title":"Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer","volume":"219","author":"Falconer","year":"1994","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ccell.2026.03.012_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113259","article-title":"Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer","volume":"9","author":"Fujiwara","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2026.03.012_bib121","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib122","first-page":"3261","article-title":"Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients","volume":"21","author":"Kilgour","year":"2013","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib123","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lungcan.2011.10.009","article-title":"Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer","volume":"76","author":"Jones","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib124","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1074\/mcp.M116.063313","article-title":"Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma","volume":"16","author":"Muqaku","year":"2017","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.ccell.2026.03.012_bib125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/RTI.0000000000000428","article-title":"Computed Tomography-based Body Composition Analysis and Its Role in Lung Cancer Care","volume":"35","author":"Troschel","year":"2020","journal-title":"J. Thorac. Imaging"},{"key":"10.1016\/j.ccell.2026.03.012_bib126","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/jcsm.12831","article-title":"Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review","volume":"12","author":"McGovern","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13664","article-title":"CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies","volume":"16","author":"Giri","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1634\/theoncologist.2017-0255","article-title":"Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer","volume":"23","author":"Nipp","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.ccell.2026.03.012_bib129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1177\/02841851241261703","article-title":"Predicting cachexia in hepatocellular carcinoma patients: a nomogram based on MRI features and body composition","volume":"65","author":"Li","year":"2024","journal-title":"Acta Radiol."},{"key":"10.1016\/j.ccell.2026.03.012_bib131","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.21037\/qims.2020.03.02","article-title":"Body composition with dual energy X-ray absorptiometry: from basics to new tools","volume":"10","author":"Messina","year":"2020","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/j.ccell.2026.03.012_bib132","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1148\/radiol.2020201640","article-title":"Population-Scale CT-based Body Composition Analysis of a Large Outpatient Population Using Deep Learning to Derive Age-Sex-and Race-specific Reference Curves","volume":"298","author":"Magudia","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.ccell.2026.03.012_bib133","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s42255-025-01434-3","article-title":"Multi-omics profiling of cachexia-targeted tissues reveals a spatio-temporally coordinated response to cancer","volume":"8","author":"Morigny","year":"2026","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib134","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/jcsm.13321","article-title":"Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series","volume":"14","author":"McDonald","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib135","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/jcsm.13248","article-title":"Hand grip strength in patients with advanced cancer: A prospective study","volume":"14","author":"Hadzibegovic","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib136","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/01635581.2023.2276486","article-title":"The Relationship between Exercise Capacity and Muscle Strength, Physical Activity, Fatigue and Quality of Life in Patients with Cancer Cachexia","volume":"76","author":"Polat","year":"2024","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib137","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3390\/cells11192987","article-title":"2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle","volume":"11","author":"Wei","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ccell.2026.03.012_bib138","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41586-025-09502-0","article-title":"Molecular subtypes of human skeletal muscle in cancer cachexia","volume":"646","author":"Bhatt","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.03.012_bib139","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nm.3686","article-title":"Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development","volume":"20","author":"Mayers","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib140","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12209","article-title":"Circulating Activin A predicts survival in cancer patients","volume":"8","author":"Loumaye","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib141","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13539-012-0075-5","article-title":"Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers","volume":"3","author":"Utech","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib142","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","article-title":"Cancer cachexia: a nutritional or a systemic inflammatory syndrome?","volume":"127","author":"McGovern","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2026.03.012_bib143","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO Guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib144","first-page":"265","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer","volume":"8","author":"Deans","year":"2005","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ccell.2026.03.012_bib145","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/jcsm.13638","article-title":"Tocilizumab for Advanced Non-Small-Cell Lung Cancer With Concomitant Cachexia: An Observational Study","volume":"15","author":"Du","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib146","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib147","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib148","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2204619","article-title":"Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRAS(G12C) Mutation","volume":"387","author":"J\u00e4nne","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib149","first-page":"18","article-title":"A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia","volume":"6","author":"Wiedenmann","year":"2008","journal-title":"J. Support Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib150","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1200\/JCO.23.01965","article-title":"Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia","volume":"43","author":"Chen","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib151","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1053\/j.gastro.2022.02.017","article-title":"Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-beta Signaling Axis in Pancreatic Cancer","volume":"162","author":"Shi","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2026.03.012_bib152","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jcsm.12331","article-title":"LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial","volume":"9","author":"Golan","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib153","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1078-0432.CCR-23-1631","article-title":"A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia","volume":"30","author":"Crawford","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib154","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the Treatment of Cancer Cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib155","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111947","article-title":"GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia","volume":"42","author":"Kim-Muller","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2026.03.012_bib157","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.4081\/ejtm.2018.7590","article-title":"Chemotherapy-induced muscle wasting: association with NF-kappaB and cancer cachexia","volume":"28","author":"Damrauer","year":"2018","journal-title":"Eur. J. Transl. Myol."},{"key":"10.1016\/j.ccell.2026.03.012_bib158","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/jcsm.12760","article-title":"Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice","volume":"12","author":"Sakai","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib159","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00424-017-2045-4","article-title":"Effect of acute treadmill exercise on cisplatin-induced muscle atrophy in the mouse","volume":"469","author":"Sakai","year":"2017","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ccell.2026.03.012_bib160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1440-1681.13024","article-title":"Dexamethasone exacerbates cisplatin-induced muscle atrophy","volume":"46","author":"Sakai","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ccell.2026.03.012_bib161","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cmet.2016.10.010","article-title":"Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity","volume":"24","author":"Flint","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.ccell.2026.03.012_bib162","article-title":"Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC","volume":"1","author":"Miyawaki","year":"2020","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.ccell.2026.03.012_bib163","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","article-title":"Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)","volume":"18","author":"Crawford","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ccell.2026.03.012_bib164","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jcsm.12050","article-title":"Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting","volume":"7","author":"Penna","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fphys.2014.00503","article-title":"Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes","volume":"5","author":"McLean","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ccell.2026.03.012_bib166","article-title":"A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution","volume":"43","author":"Zhang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2026.03.012_bib167","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1172\/JCI128411","article-title":"Neuromuscular junctions are stable in patients with cancer cachexia","volume":"130","author":"Boehm","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2026.03.012_bib168","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0038-1676473","article-title":"Contemporary Opportunity for Prehabilitation as Part of an Enhanced Recovery after Surgery Pathway in Colorectal Surgery","volume":"32","author":"Ven Fong","year":"2019","journal-title":"Clin. Colon Rectal Surg."},{"key":"10.1016\/j.ccell.2026.03.012_bib169","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/SLA.0000000000005878","article-title":"Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial","volume":"278","author":"Ngo-Huang","year":"2023","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ccell.2026.03.012_bib170","doi-asserted-by":"crossref","DOI":"10.1177\/1534735420986615","article-title":"The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment","volume":"20","author":"Parker","year":"2021","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.ccell.2026.03.012_bib171","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.freeradbiomed.2013.08.191","article-title":"The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle","volume":"65","author":"Gilliam","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ccell.2026.03.012_bib172","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12944-017-0638-8","article-title":"Chemotherapy diminishes lipid storage capacity of adipose tissue in a preclinical model of colon cancer","volume":"16","author":"Ebadi","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ccell.2026.03.012_bib173","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2026.03.012_bib174","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1016\/j.cell.2025.07.016","article-title":"Vagal blockade of the brain-liver axis deters cancer-associated cachexia","volume":"188","author":"Garrett","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.012_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110733","article-title":"Exploring the potential hypothalamic role in mediating cisplatin-induced negative energy balance","volume":"385","author":"Kim","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ccell.2026.03.012_bib176","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/cbf.3127","article-title":"Hypothalamic energy metabolism is impaired by doxorubicin independently of inflammation in non-tumour-bearing rats","volume":"33","author":"Antunes","year":"2015","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ccell.2026.03.012_bib177","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial","volume":"8","author":"Solheim","year":"2018","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.ccell.2026.03.012_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13871","article-title":"A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO)","volume":"16","author":"Mitsunaga","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib179","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jcsm.13478","article-title":"Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series","volume":"15","author":"Brown","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ccell.2026.03.012_bib180","article-title":"Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior","volume":"7","author":"Aryal","year":"2023","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.ccell.2026.03.012_bib181","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ccell.2026.03.012_bib182","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.960341","article-title":"Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene","volume":"10","author":"Ferrara","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ccell.2026.03.012_bib183","first-page":"2990","article-title":"Muscle weakness caused by cancer and chemotherapy is associated with loss of motor unit connectivity","volume":"11","author":"Huot","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.012_bib184","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","article-title":"Mediators of cachexia in cancer patients","volume":"66","author":"Argil\u00e9s","year":"2019","journal-title":"Nutrition"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610826001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610826001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:06:14Z","timestamp":1778817974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610826001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":184,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1535610826001662"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2026.03.012","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cachexia: A tumor-driven disorder of whole-body homeostasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2026.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}